Can Toradol (ketorolac) be used for postoperative pain after a dilation and curettage (D&C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketorolac for Postoperative Pain After D&C

Yes, ketorolac (Toradol) can be given for postoperative pain after a dilation and curettage (D&C) procedure, but with important caveats regarding bleeding risk and duration of use.

Key Recommendation

Ketorolac is appropriate for short-term postoperative pain management after D&C when used as part of a multimodal analgesic approach. However, given the procedure's inherent bleeding risk and ketorolac's effects on hemostasis, careful patient selection and timing are critical.

Evidence-Based Approach

Efficacy for Gynecologic Procedures

While the provided evidence doesn't include D&C-specific studies, research on first-trimester surgical abortion (a similar uterine procedure) provides relevant guidance:

  • Intramuscular ketorolac (60 mg) showed no superior pain control compared to oral ibuprofen (800 mg) for first-trimester surgical abortion 1
  • Intravenous ketorolac (30 mg) perioperatively demonstrated lower postoperative pain scores but the difference was not statistically significant compared to placebo 2
  • The primary benefit was reduced acetaminophen use (6.5% vs 35.6%) rather than dramatic pain reduction 2

General Postoperative Pain Evidence

For broader surgical contexts, ketorolac demonstrates:

  • Substantial pain relief with a number needed to treat of 2.4-2.5 for achieving 50% pain relief 3
  • Opioid-sparing effects, particularly at 60 mg doses, reducing morphine equivalent consumption by 1.64 mg 4
  • Reduced postoperative nausea and vomiting at 60 mg doses (odds ratio 0.49) 4

Critical Safety Considerations for D&C

Bleeding Risk - The Primary Concern

Ketorolac affects platelet aggregation and hemostasis, which is particularly relevant for D&C procedures 5:

  • The FDA label explicitly warns about perioperative bleeding complications, including postoperative hematomas and wound bleeding 5
  • Perioperative use should be avoided when hemostasis is critical 5
  • Studies in gynecologic procedures showed no significant increase in perioperative blood loss 2, but this requires careful monitoring

Practical Algorithm for D&C Use

AVOID ketorolac if:

  • Patient has coagulation disorders
  • Patient is on anticoagulants (warfarin, heparin) or antiplatelet agents
  • History of peptic ulcer disease or GI bleeding
  • Renal impairment (serum creatinine indicating advanced disease)
  • Known hypersensitivity to NSAIDs or aspirin triad

CONSIDER ketorolac if:

  • Patient has normal coagulation and renal function
  • No contraindications to NSAIDs
  • Moderate to severe pain expected
  • Part of multimodal analgesia strategy

Dosing Recommendations

Based on FDA labeling and clinical evidence 5:

  • Timing: Administer at the end of the procedure (not preoperatively) to minimize bleeding risk
  • Route: Intravenous preferred (15-30 mg) 6, 7
  • Duration: Maximum 5 days total use, though most D&C patients require only 1-2 days 5
  • Transition: Switch to oral NSAIDs (ibuprofen 400-600 mg) as soon as tolerated

Multimodal Approach for D&C Pain

Rather than relying solely on ketorolac, implement:

  1. First-line: Oral acetaminophen (975-1000 mg) preoperatively or immediately postoperatively 7
  2. Second-line: Ketorolac 15-30 mg IV at procedure completion (if no contraindications) 7
  3. Transition: Oral ibuprofen 600-800 mg every 6-8 hours 6
  4. Rescue: Short-acting opioids as needed for breakthrough pain

Common Pitfalls to Avoid

  • Don't use ketorolac preoperatively for D&C - wait until hemostasis is achieved
  • Don't exceed 5 days of total ketorolac use 5
  • Don't use in patients with aspirin sensitivity - risk of severe bronchospasm 5
  • Don't assume higher doses are better - 15-20 mg may be as effective as 30 mg with potentially fewer adverse effects 8
  • Don't use as monotherapy - always part of multimodal analgesia

Alternative Consideration

Given the bleeding concerns specific to D&C and the modest benefits shown in similar gynecologic procedures 1, 2, oral ibuprofen 800 mg may be equally effective with a better safety profile for routine D&C procedures. Reserve ketorolac for patients with more severe pain or those unable to tolerate oral medications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.